share_log

Invitae Analyst Ratings

Invitae Analyst Ratings

邀请分析师评级
Benzinga ·  2023/10/23 08:49
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
10/23/2023 -7.83% Goldman Sachs $1 → $0.5 Maintains Sell
10/20/2023 -7.83% Goldman Sachs $1 → $0.5 Maintains Sell
08/15/2023 -7.83% Piper Sandler $1.5 → $0.5 Maintains Underweight
07/24/2023 84.33% Goldman Sachs $1.5 → $1 Maintains Sell
07/21/2023 84.33% Goldman Sachs $1.5 → $1 Maintains Sell
05/15/2023 — Raymond James Downgrades Market Perform → Underperform
05/11/2023 176.5% Goldman Sachs $2 → $1.5 Maintains Sell
03/03/2023 222.58% Piper Sandler $2.25 → $1.75 Maintains Underweight
01/31/2023 268.66% Goldman Sachs → $2 Downgrades Neutral → Sell
11/09/2022 453% SVB Leerink $2.5 → $3 Maintains Market Perform
08/25/2022 84.33% Credit Suisse → $1 Initiates Coverage On → Underperform
08/18/2022 314.75% Piper Sandler $2.5 → $2.25 Maintains Underweight
08/10/2022 — JP Morgan Downgrades Neutral → Underweight
08/10/2022 360.83% SVB Leerink $2 → $2.5 Maintains Market Perform
07/26/2022 360.83% Cowen & Co. $8 → $2.5 Downgrades Outperform → Market Perform
07/21/2022 — Raymond James Downgrades Outperform → Market Perform
07/19/2022 1374.65% Cowen & Co. $10 → $8 Maintains Outperform
07/19/2022 — Benchmark Downgrades Buy → Hold
07/19/2022 268.66% SVB Leerink $8 → $2 Downgrades Outperform → Market Perform
06/13/2022 1005.99% Benchmark $13 → $6 Maintains Buy
06/03/2022 360.83% Piper Sandler → $2.5 Initiates Coverage On → Underweight
05/05/2022 1466.82% Raymond James $10.5 → $8.5 Maintains Outperform
05/04/2022 3033.64% Morgan Stanley $18 → $17 Maintains Equal-Weight
04/19/2022 1743.32% Goldman Sachs $14 → $10 Maintains Neutral
04/18/2022 1835.48% Raymond James $15 → $10.5 Maintains Outperform
02/28/2022 2664.98% Raymond James $36 → $15 Maintains Outperform
02/25/2022 4508.29% SVB Leerink $30 → $25 Maintains Outperform
02/15/2022 3217.97% Morgan Stanley $37 → $18 Maintains Equal-Weight
11/09/2021 6535.94% Raymond James $38 → $36 Maintains Outperform
08/05/2021 7273.27% Morgan Stanley $41 → $40 Maintains Equal-Weight
08/04/2021 6351.61% Benchmark → $35 Upgrades Hold → Buy
06/21/2021 6351.61% Wells Fargo $30 → $35 Maintains Equal-Weight
06/15/2021 6720.28% Raymond James → $37 Initiates Coverage On → Outperform
06/03/2021 5982.95% Goldman Sachs → $33 Initiates Coverage On → Neutral
05/25/2021 5429.95% Wells Fargo → $30 Initiates Coverage On → Equal-Weight
05/06/2021 7457.6% Morgan Stanley $45 → $41 Maintains Equal-Weight
05/05/2021 9116.59% SVB Leerink $65 → $50 Maintains Outperform
04/05/2021 8747.93% Oppenheimer → $48 Upgrades Perform → Outperform
02/22/2021 8194.93% Morgan Stanley $41 → $45 Maintains Equal-Weight
02/19/2021 8194.93% Morgan Stanley $41 → $45 Maintains Equal-Weight
02/18/2021 10591.24% Ladenburg Thalmann $46.5 → $58 Upgrades Neutral → Buy
02/18/2021 11881.57% SVB Leerink $64 → $65 Maintains Outperform
02/01/2021 — Oppenheimer Downgrades Outperform → Perform
01/20/2021 11697.24% SVB Leerink $48 → $64 Maintains Outperform
11/06/2020 7457.6% Morgan Stanley $38 → $41 Maintains Equal-Weight
11/06/2020 8747.93% SVB Leerink $44 → $48 Maintains Outperform
11/03/2020 8010.6% SVB Leerink $34 → $44 Maintains Outperform
10/14/2020 8194.93% JP Morgan → $45 Downgrades Overweight → Neutral
09/09/2020 6904.61% Morgan Stanley → $38 Initiates Coverage On → Equal-Weight
08/05/2020 6167.28% SVB Leerink $40 → $34 Maintains Outperform
07/15/2020 7273.27% SVB Leerink $25 → $40 Maintains Outperform
07/01/2020 — Benchmark Downgrades Buy → Hold
05/06/2020 4508.29% SVB Leerink $20 → $25 Maintains Outperform
04/08/2020 3586.64% Benchmark $31 → $20 Maintains Buy
03/04/2019 — Chardan Capital Initiates Coverage On → Buy
日期 上行/下行 分析公司 目标价格变化 评级变化 上一次/当前评级
10/23/2023 -7.83% 高盛 $1→$0.5 维护 卖
10/20/2023 -7.83% 高盛 $1→$0.5 维护 卖
2023年08月15日 -7.83% 派珀·桑德勒 $1.5→$0.5 维护 体重不足
07/24/2023 84.33% 高盛 $1.5→$1 维护 卖
07/21/2023 84.33% 高盛 $1.5→$1 维护 卖
2023年05月15日 - 雷蒙德·詹姆斯 评级下调 市场表现→表现不佳
2023年05月11日 176.5% 高盛 $2→$1.5 维护 卖
03/03/2023 222.58% 派珀·桑德勒 $2.25→$1.75 维护 体重不足
2023年1月31日 268.66% 高盛 →$2 评级下调 中性→销售
11/09/2022 453% SVB Leerink $2.5→$3 维护 市场表现
2022年08月25日 84.33% 瑞士信贷 →$1 开始承保 →表现不佳
2022/08/18 314.75% 派珀·桑德勒 $2.5→$2.25 维护 体重不足
2022年08月10日 - 摩根大通 评级下调 中性→减持
2022年08月10日 360.83% SVB Leerink $2→$2.5 维护 市场表现
07/26/2022 360.83% 考恩公司 $8→$2.5 评级下调 跑赢→市场表现
07/21/2022 - 雷蒙德·詹姆斯 评级下调 跑赢→市场表现
07/19/2022 1374.65% 考恩公司 $10→$8 维护 跑赢大盘
07/19/2022 - 基准 评级下调 购买→Hold
07/19/2022 268.66% SVB Leerink $8→$2 评级下调 跑赢→市场表现
2022/06/13 1005.99% 基准 $13→$6 维护 买
06/03/2022 360.83% 派珀·桑德勒 →$2.5 开始承保 →减持
05/05/2022 1466.82% 雷蒙德·詹姆斯 $10.5→$8.5 维护 跑赢大盘
05/04/2022 3033.64% 摩根士丹利 $18→$17 维护 等重
04/19/2022 1743.32% 高盛 $14→$10 维护 中性
04/18/2022 1835.48% 雷蒙德·詹姆斯 $15→$10.5 维护 跑赢大盘
02/28/2022 2664.98% 雷蒙德·詹姆斯 $36→$15 维护 跑赢大盘
02/25/2022 4508.29% SVB Leerink $30→$25 维护 跑赢大盘
02/15/2022 3217.97% 摩根士丹利 $37→$18 维护 等重
11/09/2021 6535.94% 雷蒙德·詹姆斯 $38→$36 维护 跑赢大盘
08/05/2021 7273.27% 摩根士丹利 $41→$40 维护 等重
08/04/2021 6351.61% 基准 →$35 升级 持有→购买
2021/06/21 6351.61% 富国银行 $30→$35 维护 等重
2021/06/15 6720.28% 雷蒙德·詹姆斯 →$37 开始承保 →跑赢大盘
06/03/2021 5982.95% 高盛 →$33 开始承保 →中性
2021/05/25 5429.95% 富国银行 →$30 开始承保 →等重
05/06/2021 7457.6% 摩根士丹利 $45→$41 维护 等重
05/05/2021 9116.59% SVB Leerink $65→$50 维护 跑赢大盘
04/05/2021 8747.93% 奥本海默 →$48 升级 →表现强于大盘
02/22/2021 8194.93% 摩根士丹利 $41→$45 维护 等重
02/19/2021 8194.93% 摩根士丹利 $41→$45 维护 等重
02/18/2021 10591.24% 拉登堡·塔尔曼 $46.5→$58 升级 中性→购买
02/18/2021 11881.57% SVB Leerink $64→$65 维护 跑赢大盘
02/01/2021 - 奥本海默 评级下调 超越→表现
01/20/2021 11697.24% SVB Leerink $48→$64 维护 跑赢大盘
11/06/2020 7457.6% 摩根士丹利 $38→$41 维护 等重
11/06/2020 8747.93% SVB Leerink $44→$48 维护 跑赢大盘
11/03/2020 8010.6% SVB Leerink $34→$44 维护 跑赢大盘
10/14/2020 8194.93% 摩根大通 →$45 评级下调 超重→中性
09/09/2020 6904.61% 摩根士丹利 →$38 开始承保 →等重
08/05/2020 6167.28% SVB Leerink $40→$34 维护 跑赢大盘
07/15/2020 7273.27% SVB Leerink $25→$40 维护 跑赢大盘
07/01/2020 - 基准 评级下调 购买→Hold
05/06/2020 4508.29% SVB Leerink $20→$25 维护 跑赢大盘
04/08/2020 3586.64% 基准 $31→$20 维护 买
2019/03/04 - 查尔丹资本 开始承保 →购买

What is the target price for Invitae (NVTA)?

Invitae(NVTA)的目标价是多少？

The latest price target for Invitae (NYSE: NVTA) was reported by Goldman Sachs on October 23, 2023. The analyst firm set a price target for $0.50 expecting NVTA to fall to within 12 months (a possible -7.83% downside). 10 analyst firms have reported ratings in the last year.

高盛于2023年10月23日报告了Invitae(纽约证券交易所代码：NVTA)的最新目标价。这家分析公司将NVTA的目标价设定为0.50美元，预计NVTA将在12个月内跌至(可能下跌7.83%)。去年有10家分析公司公布了评级。

What is the most recent analyst rating for Invitae (NVTA)?

Invitae(NVTA)的最新分析师评级是多少？

The latest analyst rating for Invitae (NYSE: NVTA) was provided by Goldman Sachs, and Invitae maintained their sell rating.

对Invitae(纽约证券交易所代码：NVTA)的最新分析师评级由高盛提供，Invitae维持其卖出评级。

When is the next analyst rating going to be posted or updated for Invitae (NVTA)?

Invitae(NVTA)的下一次分析师评级将于何时发布或更新？

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Invitae, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Invitae was filed on October 23, 2023 so you should expect the next rating to be made available sometime around October 23, 2024.

分析师在进行了广泛的研究后得出了股票评级，其中包括查阅公共财务报表，与Invitae的高管和客户交谈，以及收听收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。Invitae的上一次评级是在2023年10月23日提交的，所以你应该预计下一次评级将在2024年10月23日左右提供。

Is the Analyst Rating Invitae (NVTA) correct?

分析师评级邀请函(NVTA)正确吗？

While ratings are subjective and will change, the latest Invitae (NVTA) rating was a maintained with a price target of $1.00 to $0.50. The current price Invitae (NVTA) is trading at is $0.54, which is out of the analyst's predicted range.

虽然评级是主观的，并将发生变化，但最新的Invitae(NVTA)评级维持不变，目标价在1.00美元至0.50美元之间。目前Invitae(NVTA)的交易价格为0.54美元，超出了分析师的预测区间。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发